NCT04692428

Brief Summary

Patients were randomly assigned to tow groups: infrainguinal ultrasound guided iliaca fascia block (FIBSI) and femoral nerve block (FNB) for FIBSI, the probe is placed transversely between anterior superior iliac spine (ASIS) and the pubic spine. The transducer is translated laterally to identify the Sartorius muscle. Cephalic inclination of the probe. The medial end of the transducer faces towards the umbilicus, which is the final position. The 100mm neurostimulation needle is advanced in the In Plan approach to pass through the iliac fascia. Once the correct position is confirmed, 30 ml of 1% Ropivacaine is gradually injected between the iliac fascia and the iliac muscle. For FNB, the probe was placed under the inguinal ligament. The femoral vessels and the nerve section are visualized; The 100mm neurostimulation needle is advanced in the In Plan approach and 30ml of 1% Ropivacaine has been injected along the nerve sheath

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2019

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

December 25, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 31, 2020

Completed
Last Updated

January 5, 2021

Status Verified

January 1, 2021

Enrollment Period

8 months

First QC Date

December 25, 2020

Last Update Submit

January 2, 2021

Conditions

Keywords

analgesiahip fracturenerve block

Outcome Measures

Primary Outcomes (1)

  • Positioning pain before performing spinal anesthesia

    Pain in positioning was assessed by measuring the simple verbal scale (0= no pain- 4= worst pain possible) after 20 minutes for realization block

    20 minutes after realization of blocks

Secondary Outcomes (4)

  • Postoperative pain

    at the third, sixth, twelfth and twenty-four hours postoperatively

  • quality of patient placement in the sitting position

    after 20 minutes of realization of block

  • The level of sensory block at 20 minutes after realization of block

    before and 20 minutes after realization of blocks

  • Patient satisfaction

    five minutes after the end of the realization of spinal anesthesia

Study Arms (2)

FIBSI group

EXPERIMENTAL

ultrasound supra inguinal Fascia iliaca block

Procedure: Locoregional analgesia

FNB group

EXPERIMENTAL

ultrasound femoral nerve block

Procedure: Locoregional analgesia

Interventions

the supra-inguinal fascia iliaca block versus the femoral nerve block

FIBSI groupFNB group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA (American Society of Anesthesiologists) class I, II, and III patients scheduled for emergency surgery with the diagnosis of proximal femur fracture

You may not qualify if:

  • hemorrhagic diathesis,
  • peripheral neuropathies,
  • allergy to amide local anaesthetics,
  • mental disorders,
  • those on analgesics within 8 hour prior to performing nerve block

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mechaal Benali

Nabeul, Mrezga, 8000, Tunisia

Location

MeSH Terms

Conditions

Hip FracturesAgnosia

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg InjuriesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • mechaal benali, PROFESSOR

    university manar Tunis tunisia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 25, 2020

First Posted

December 31, 2020

Study Start

April 20, 2019

Primary Completion

December 20, 2019

Study Completion

December 20, 2019

Last Updated

January 5, 2021

Record last verified: 2021-01

Locations